MAP2K7 and esophageal squamous cell carcinoma: CST1 has also been shown to have oncogenic potential in ESCC development by our pilot study, as demonstrated by its aberrantly high expression and effect of CST1 on cell migration and invasion via the MEK/ERK signaling pathway in ESCC30.